Enter your login e-mail to the account
Search
Search parameters
Search results
- Tlačové správy
(4/2010, Information & comments ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - NOVINKY VO FARMAKOTERAPII: KATEGORIZÁCIA OD 1. JANUÁRA 2009
Ing. Mgr. Dagmar Hroncová
(11/2008, Informations )
- Bipolar affective disorder in a female patient with breast cancer as a complication of anticancer therapy
doc. MUDr. Ladislav Slováček, Ph.D., MUDr. Birgita Slováčková, Ph.D.
(3/2013, Original articles & case reports )
- The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Current status and perspectives of treatment for brain metastases
MUDr. Markéta Pospíšková, MUDr. Milan Kohoutek, MUDr. Michaela Zábojníková
(5/2011, From the boundary of neurology )
- Systemic treatment of metastatic triple negative breast cancer
MUDr. Emília Fatkulinová
(5/2018, Review articles ) - Sacituzumab govitekan – drug profile
MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Drugs & drug classes ) - Publikujeme v zahraničí
(6/2014, Information & comments ) - Správa zo 17. celoštátnej pracovnej konferencie SEKCAMA konanej v dňoch 17. a 18. mája 2012
doc. MUDr. Vladimír Bella, PhD.
(4/2012, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(4/2012, Information & comments ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(1/2008, Review articles ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - EPIDEMIOLOGY, AETIOLOGY, DIAGNOSIS, AND SCREENING OF LUNG CANCER
doc. MUDr. Peter Beržinec, CSc.
(1/2006, Review articles ) - XI. KOŠICKÉ CHEMOTERAPEUTICKÉ DNI
MUDr. Michal Mego, PhD.
(1/2008, Events ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Pediatric oncology on the verge of 21. century: perspectives, aims and future visions
as. MUDr. Viera Bajčiová, CSc.
(1/2007, Review articles ) - SPRÁVA Z 30. SAN ANTONIO BREAST CANCER SYMPOSIUM, 13. – 16. DECEMBER 2007
MUDr. Vladimír Malec
(1/2008, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - New approaches in the testing of HER2 status in the biopsies of breast carcinoma patients
prof. MUDr. Lukáš Plank, CSc.
(2/2024, Review articles ) - Správa z X. Košických chemoterapeutických dní, 23. – 24. november 2006
MUDr. Radovan Barilla
(1/2007, Events ) - Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - Správa z 18. celoštátnej pracovnej konferencie SEKCAMA, 25. a 26. apríl 2013, Bratislava
doc. MUDr. Vladimír Bella, PhD.
(3/2013, Events ) - Správa z konferencie Aktuálne problémy v manažmente gastrointestinálnych malignít
MUDr. Tomáš Šálek, MUDr. Peter Pichňa, CSc.
(1/2011, Events ) - CURRENT ALTERNATIVES FOR SECOND LINE CHEMOTHERAPY OF RECURRENT CIS-PLATIN REFRACTORY EPITHELIAL OVARIAN CANCER
MUDr. Radovan Barilla
(2/2006, Review articles ) - NEW „MARKERS AND PROGNOSTIC FACTORS“ – THE SURGICAL PATHOLOGIST‘S VIEW
prof. MUDr. Štefan Galbavý, CSc.
(3/2006, Review articles ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Impact of CDK 4/6 inhibitors on overall survival of patients with advanced breast cancer – in the light of new data
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2024, Company information ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Breast cancer of young women – case report
doc. MUDr. Jana Slobodníková, CSc., h. prof.
(6/2013, Original articles & case reports ) - Anthracyclines in treating metastatic breast cancer
MUDr. Katarína Petráková
(3/2014, Review articles ) - Follow-up after treatment in patients with malignant disease
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Andrej Rosík, MUDr. Miroslava Stratená, MUDr. Mário Bôžik
(3/2015, Main topic ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(1/2009, Information & comments ) - Diskusné fórum onkológov
(1/2009, Discussion forum ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFRmutant lung cancers
doc. MUDr. Peter Beržinec, CSc.
(6/2013, Information & comments ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - LHRH analogs in treatment of breast cancer
MUDr. Ján Rajec, PhD., MUDr. Lucia Dzurillová
(3/2015, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - New trends in the immunotherapy of cancer
MUDr. Ján Lakota, CSc.
(6/2016, Review articles ) - Current position of vinorelbine within complex breast cancer treatment
MUDr. Silvia Jurišová, MUDr. Miroslava Malejčíková
(6/2016, Drugs & drug classes ) - Treatment of patients with HR+, HER2- PIK3CA-mutated advanced/metastatic breast cancer: results of trial SOLAR-1
MUDr. Andrej Rosík
(2/2021, Review articles ) - Inflammatory breast cancer
doc. MUDr. Mária Wagnerová, CSc.
(2/2012, Main topic ) - Significance of neoadjuvant treatment in patients with early breast cancer – perspective of surgeon
MUDr. Marián Karaba, prof. MUDr. Juraj Benca, PhD., MPH, MUDr. Terézia Lauková, doc. MUDr. Daniel Pinďák, PhD., MUDr. Dominika Rusnáková, MUDr. Martina Vranovská, MUDr. Otília Osifová
(2/2017, Review articles ) - Prophylactic procedures in women with gene mutations BRCA1 and BRCA2
doc. MUDr. Vladimír Bella, PhD.
(2/2012, Main topic ) - Novinky zo San Antonio Breast Cancer Symposium
prof. MUDr. Stanislav Špánik, CSc., MUDr. Vladimír Malec, PhD., MUDr. Mária Rečková
(1/2013, Events ) - Metastatic colorectal cancer – results of treatment of the primary tumor localization
MUDr. Vanda Ušáková, PhD.
(2/2017, Review articles ) - Správa z Best of ASCO® Slovakia 2015
MUDr. Mária Rečková
(6/2015, Events ) - Radiotherapy for breast cancer
MUDr. Elena Bolješíková, CSc., MUDr. Andrea Ligačová
(2/2012, Main topic ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Chemotherapy for carcinoma of stomach
MUDr. Tomáš Šálek
(3/2011, Review articles ) - Tumor Heterogeneity and Drug Resistance
Mgr. Lucia Kučerová, PhD., Mgr. Svetlana Školeková,, RNDr. Zuzana Kozovská, PhD.
(6/2015, Review articles ) - Cancer drug consumption in Slovakia and its economic impact – development and trends
prof. RNDr. Viliam Foltán, CSc., PharmDr. Veronika Dubajová, Mgr. Katarína Gatialová , Mgr. Katarína Bellová
(3/2011, Review articles ) - Správa z Best of ASCO Slovakia 2009
MUDr. Mária Rečková
(6/2009, Events ) - ECCO15 – ESMO34, Berlín 20. – 24. 9. 2009
MUDr. Juraj Beniak
(6/2009, Information & comments ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(6/2009, Information & comments ) - Systemic treatment of breast cancer in pregnancy
MUDr. Oľga Szegheőová
(3/2016, Main topic ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - The characteristics of lung cancer in young adults
MUDr. Peter Kasan, MUDr. Mária Černá, CSc., MUDr. Radka Cahajlová, MUDr. Marián Marták, MUDr. Milada Veselá, MUDr. Lucia Denková, MUDr. Zuzana Šviheľová-Lišková
(3/2016, Original articles & case reports ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - MEDZINÁRODNÝ KONGRES PROTIRAKOVINOVEJ LIEČBY V PARÍŽI
MUDr. Zuzana Hlavatá
(2/2007, Events ) - Testing molecular biomarkers in the treatment and management of patients with lung cancer in Slovakia
RNDr. Regína Lohajová Behulová, PhD., RNDr. Romana Valenčíková, PhD., Dr. Med. Veronika Urbán
(S2/2023, Review articles ) - 15. celoštátna konferencia Sekcama
doc. MUDr. Vladimír Bella, PhD.
(3/2010, Events ) - Therapeutic procedures in the treatment of advanced triple-negative breast cancer – a nationwide survey among selected oncologists from oncology institutes and regional cancer centers in Slovakia
MUDr. Radovan Barila, PhD., MUDr. Elena Marušáková, MBA, Ing. Jan Žigmond
(3/2024, Review articles ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - VI. Dni mladých onkológov vo Vyhniach
MUDr. Oľga Szegheőová
(5/2010, Events ) - Personalised medicine and cancer of unknown primary
RNDr. Gabriel Minárik, PhD.
(4/2013, Main topic ) - Neratinib in treatment of HER2+ breast cancer – drug profile
MUDr. Radovan Barila, PhD.
(3/2020, Drugs & drug classes ) - Správa zo zasadnutia Výboru Slovenskej onkologickej spoločnosti, 24. 09. 2010
Zapísal: doc. MUDr. Peter Beržinec, CSc.
(5/2010, Information & comments ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Current options and strategies for choosing treatment for metastatic colorectal cancer after first-line failure
MUDr. Juraj Beniak
(6/2020, Review articles ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Postavenie inhíbitorov aromatázy v adjuvantnej liečbe potmenopauzálnych žien s hormonálne pozitívnym karcinómom prsníka
MUDr. Jana Obertová
(2/2009, Review articles ) - Cardiotoxicity of drugs used in adjuvant therapy of breast cancer
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Katarína Ševčíková
(2/2009, Review articles ) - Zriedkavé epitelové nádory prsníka
MUDr. Mária Rečková, PhD.
(3/2018, Main topic ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - A comprehensive view of the treatment of HER2-positive breast cancer
MUDr. Bela Mriňáková, PhD., MPH
(2/2022, Main topic ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Molecular pathology of prostate carcinoma (part 2)
MUDr. Katarína Macháleková, doc. MUDr. Karol Kajo, PhD., Mgr. Petra Tilandyová, RNDr. Zora Lasabová, PhD., MUDr. Roman Tomaškin
(4/2009, Review articles ) - Trastuzumab deruxtecan – drug profile and use in the treatment of advanced HER2-positive breast cancer
MUDr. Radovan Barila, PhD., MUDr. Lenka Svobodová, MUDr. Ján Bujňák, PhD.
(2/2022, Drugs & drug classes ) - Správy z podujatia ASCO Chicago 2015
(4/2015, Events ) - Current treatment options for advanced cholangiocarcinoma
MUDr. Benjamin Špánik, MUDr. Tomáš Šálek, MUDr. Natália Pazderová, MUDr. Eva Zomborská, MUDr. Mgr. Zuzana Mináriková, PhD., MUDr. Ján Slopovský, MUDr. Štefan Pörsök, PhD., MPH
(5/2022, Main topic ) - Správa z 32nd Annual CTRC – AACR San Antonio Breast Cancer Symposium 9. – 13. 12. 2009
doc. MUDr. Karol Kajo, PhD.
(1/2010, Events ) - THE INTRODUCTION TO INTERPRETATION OF CLINICAL TRIALS – Part II.
MUDr. Michal Mego, PhD., MUDr. Mária Rečková
(3/2008, Review articles ) - Molecular pathology of selected types of ovarian cancer
doc. MUDr. Karol Kajo, PhD.
(5/2014, Main topic ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - SPRÁVA Z 13. CELOŠTÁTNEJ PRACOVNEJ KONFERENCIE SEKCAMA S MEDZINÁRODNOU ÚČASŤOU, 23. – 25. APRÍL 2008
MUDr. Vladimír Bella, PhD., MUDr. Dušan Malatin, CSc.
(3/2008, Events ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Palliative radiotherapy – brain metastatic disease
MUDr. Elena Bolješíková, CSc., MUDr. Martin Chorváth
(5/2013, Main topic ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(3/2012, Information & comments ) - Targeted terapy of gastric cancer
MUDr. Vanda Ušáková, PhD.
(5/2014, Review articles ) - Správa z podujatia ASCO Chicago 2012
(3/2012, Events ) - Správa z XLVIII. ročníka Bratislavských onkologických dní, 6. – 7. októbra 2011
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2012, Events ) - Publikujeme v zahraničí
(4/2016, Information & comments ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - Správa z Best of ASCO® Slovakia 2011
MUDr. Mária Rečková
(1/2012, Events ) - Kam posunul trastuzumab deruxtecan liečbu HER2+ pozitívneho karcinómu prsníka?
MUDr. Miroslava Malejčíková
(2/2023, Review articles ) - CHEMOPREVENTION OF BREAST CANCER
prof. MUDr. Ľudovít M. Jurga, DrSc., prof. MUDr. Myrón Malý, CSc.
(5/2007, Review articles ) - Exosomes – new topic in diagnostics of cancer
RNDr. Ján Sedlák, DrSc., Mgr. Martina Zdurienčíková, RNDr. Paulína Gronesová, PhD., RNDr. Dana Cholujová, PhD., RNDr. Ľuba Hunáková, CSc.
(5/2015, Review articles ) - Efficacy and cardiotoxicity risk of adjuvant treatment in HER2-positive patients with breast cancer
MUDr. Jaroslava Lešková
(1/2020, Review articles ) - Úvodné slovo
MUDr. Radovan Barilla, PhD.
(1/2012, Editorial ) - Články publikované v časopise Onkológia v roku 2011 – prehľad
(1/2012, online attachment ) - V. BARDEJOVSKÉ ONKOLOGICKÉ DNI
doc. MUDr. Mária Wagnerová, CSc.
(6/2008, Events ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Hereditary cancer syndromes
RNDr. Miriam Milly, PhD., RNDr. Michal Konečný, PhD., Ing. Ľudmila Vavrová, PhD., MUDr. Olívia Hamidová, RNDr. Katarína Závodná, PhD.1, Mgr. Lenka Dolešová
(2/2015, Main topic ) - Antitumor immunity
MUDr. Ján Lakota, CSc., MUDr. Milan Žuffa, CSc.
(2/2015, Review articles ) - Circulating and disseminated tumor cells
MUDr. Michal Mego, PhD.
(6/2010, Review articles ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - Treatment of gastrointestinal stromal tumours
MUDr. Zdeněk Linke, MUDr. Jana Prausová
(4/2010, Review articles ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - THE ROLE AND LIMITS OF PATHOLOGY IN ONCOLOGY
prof. MUDr. Lukáš Plank, CSc.
(1/2006, Review articles ) - Optimal first-line treatment of mCRC
MUDr. Jana Ďurková
(1/2017, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(6/2012, Information & comments ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - Chemotherapy of hormone refractory prostate cancer
MUDr. Marta Škultétyová, MUDr. Andrea Mocná
(5/2009, Review articles ) - Abemaciclib in first-line treatment of HR+, HER2- breast cancer with visceral metastases in a premenopausal patient
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(3/2022, Case reports ) - Bratislavské onkologické dni 2009
MUDr. Michal Mego, PhD.
(5/2009, Events ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - TESTICULAR TUMOR IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS. DIFFERENCES IN BIOLOGY ACROSS THE AGE
MUDr. Viera Bajčiová, CSc.
(6/2007, Review articles ) - Treatment metastatic gastric cancer
MUDr. Vanda Ušáková, PhD.
(1/2018, Review articles ) - CLEAR CELL OVARIAN CANCOR – A CASE STORY
doc. MUDr. Lýdia Heľpianska, CSc., MUDr. Ivana Krajčovičová
(2/2006, Original articles ) - Metronomic chemotherapy in breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2018, Review articles ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles ) - Niektoré nové poznatky zo sympózia ASCO GI San Francisco 2018
MUDr. Tomáš Šálek
(1/2018, Events ) - ASCO 2008, SPRÁVA Z MEDZINÁRODNÉHO STRETNUTIA ONKOLÓGOV
MUDr. Marcela Tkáčová
(4/2008, Events ) - NEOADJUVANT SYSTEMIC TREATMENT OF OPERABLE BREAST CANCER
prof. MUDr. Stanislav Špánik, CSc.
(3/2006, Review articles ) - SIGNIFICANCE OF GENE EXPRESSION PROFILING FOR PREDICTION OF PROGNOSIS AND THERAPY RESPONSE IN BREAST CARCINOMA
prof. MUDr. Lukáš Plank, CSc., doc. MUDr. Karol Kajo, PhD.
(4/2008, Review articles )
- Acne – An overview, news in the treatment
MUDr. Katařina Fajkošová
(4/2011, Review articles )
- Pharmacogenetics in practice of a clinical pharmacologist and a pharmacist
MUDr. Olga Bartošová, Ph.D., Prof. MUDr. Ondřej Slanař, Ph.D., PharmDr. Irena Netíková, Ph.D.
(3/2016, Clinical pharmacy ) - Nové liečivá v EÚ registrované v roku 2013 (III.)
PharmDr. Peter Stanko
(2-3/2014, New drugs )
- Contemporary approaches to genetic diagnostics in clinical oncology
RNDr. Regína Lohajová Behulová, PhD., Mgr. Michal Svoboda, RNDr. Aster Alemayehu, PhD., Mgr. Lukáš Šebest, PhD.
(2/2024, Main topic )